Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

The effect of Omicron mutations at the fundamental atomic scale level

The present study provided interesting insights into the interactions of AAs at the interface between SARS-CoV-2 spike and human ACE2 receptors.

10 Feb 2022

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

In this study, researchers looked at how well molecular and antigen testing performed in symptomatic and asymptomatic close contacts of SARS-CoV-2 positive people.

10 Feb 2022

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

10 Feb 2022

Regular surveillance testing of a community can prevent Covid-19 outbreaks

Covid-19 is often asymptomatic and can lead infected individuals to spread the disease without knowing it. Yet, regular surveillance testing of a community can catch these cases and prevent outbreaks.

10 Feb 2022

U.S. workers experience clusters of socioeconomic vulnerabilities to COVID-19

COVID-19 has had a devastating impact on people's physical and mental health and has caused economic hardship. However, this adversity has disproportionately hurt certain populations-;including essential workers and women-;deepening existing disparities.

10 Feb 2022

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

A study published on the bioRxiv* preprint server evaluates molnupiravir against a panel of relevant VOCs using three efficacy models: primary human airway epithelium organoids, a ferret model of upper respiratory disease, and a Roborovski dwarf hamster model for severe COVID-19.

9 Feb 2022

Machine learning highly effective at identifying SARS-CoV-2 variants

...

9 Feb 2022

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

The recent success of Paxlovid has encouraged researchers to develop new anti-covid drugs. With this in mind, scientists from the University of Pennsylvania have been investigating a new synergistic treatment. Their research is released early as an unedited version of the manuscript to be published in the journal Nature.

9 Feb 2022

Poll: Most people over age 50 aren’t using mobile health-related apps

Mobile apps make it possible to track everything from exercise and calories to blood pressure and blood sugar, and use the information to stay on target with health goals or managing a chronic condition.

9 Feb 2022

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Researchers describe the impact of changes in the Omicron variant on a uniquely immunodominant spike-encoded CD8+ T-cell epitope.

9 Feb 2022

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

The novel coronavirus, or SARS-CoV-2, which causes the highly contagious COVID-19, has infected millions of people worldwide.

9 Feb 2022

Economic hardships and reliance on outside hep associated with high COVID-19 rates in older Latinos

Older Latinos are among the groups hardest hit by COVID-19 infection and death, yet research on the factors behind these disparities has been limited.

9 Feb 2022

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

The FDA will consider authorizing two doses of a COVID-19 vaccine for kids under 5 on an emergency basis, with the possibility for a third.

9 Feb 2022

Study shows link between loneliness and dementia risk in older adults

As social isolation in the United States has been increasing among older adults, a new study shows a notable link between loneliness and dementia risk, and one that is most striking for Americans who represent a large part of the population.

9 Feb 2022

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

In a new study, researchers evaluated healthcare workers in South Africa, presenting with SARS-CoV-2 symptoms, for infection by the Omicron variant.

9 Feb 2022

Single-cell sequencing provides detailed insight into early SARS-CoV-2 infection in the lungs

What is going on at the single-cell level in the first days of SARS-CoV-2 infection in the lungs?

9 Feb 2022

Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters

A new study estimated SARS-CoV-2 epidemiological parameters by using various sampling strategies on sequencing data of viral genomes.

9 Feb 2022

Study finds gender-based differences in risk factors associated with anxiety during the pandemic

The COVID-19 pandemic is an anxiety-inducing stressor that affects every aspect of our daily lives. A new Canadian study has found that the pandemic-related risk-factors associated with anxiety differ between men and women.

9 Feb 2022

Simulation of SARS-CoV-2 spread in the United States and India

Researchers used an ABM to simulate SARS-CoV-2 spread in the United States and India.

9 Feb 2022

Implications of the SARS-CoV-2 pandemic on influenza epidemics

A new study investigated the effect of low circulating seasonal influenza virus during the SARS-CoV-2 pandemic on the antibody titers against influenza during the same period.

9 Feb 2022

Pandemic News and Research

Further Reading

The effect of Omicron mutations at the fundamental atomic scale level

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

Regular surveillance testing of a community can prevent Covid-19 outbreaks

U.S. workers experience clusters of socioeconomic vulnerabilities to COVID-19

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

Machine learning highly effective at identifying SARS-CoV-2 variants

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Poll: Most people over age 50 aren’t using mobile health-related apps

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

Economic hardships and reliance on outside hep associated with high COVID-19 rates in older Latinos

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

Study shows link between loneliness and dementia risk in older adults

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

Single-cell sequencing provides detailed insight into early SARS-CoV-2 infection in the lungs

Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters

Study finds gender-based differences in risk factors associated with anxiety during the pandemic

Simulation of SARS-CoV-2 spread in the United States and India

Implications of the SARS-CoV-2 pandemic on influenza epidemics

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News